IIM
TYRA icon

INTECH Investment Management’s Tyra Biosciences TYRA Stock Holding History

INTECH Investment Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
7,419
+1,074
+17% +$35.5K ﹤0.01% 1702
2026
Q1 		$243K Sell
6,345
-3,456
-35% -$112K ﹤0.01% 1662
2025
Q4 		$258K Sell
9,801
-1,601
-14% -$29.4K ﹤0.01% 1843
2025
Q3 		$160K Sell
11,402
-8,517
-43% -$97.1K ﹤0.01% 2142
2025
Q2 		$191K Buy
19,919
+6,322
+46% +$60.1K ﹤0.01% 2108
2025
Q1 		$126K Buy
+13,597
New +$176K ﹤0.01% 2250

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

INTECH Investment Management's TYRA Position: Q2 2026 in Review

INTECH Investment Management increased its Tyra Biosciences (TYRA) stake by 17% in Q2 2026, buying an estimated $35.5K and bringing the position to 7,419 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

INTECH Investment Management first reported a position in TYRA in Q1 2025 and has held it in 6 quarters since. The position peaked at $258K in Q4 2025. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • INTECH Investment Management held 7,419 shares of Tyra Biosciences worth $237K as of Q2 2026.
  • INTECH Investment Management bought 1,074 Tyra Biosciences shares in Q2 2026, an estimated $35.5K.
  • Tyra Biosciences made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1702 holding.
  • INTECH Investment Management first reported a position in Tyra Biosciences in Q1 2025 and has held it in 6 quarters since.
  • INTECH Investment Management's Tyra Biosciences position peaked at $258K in Q4 2025.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.